SOTERA HEALTH CO

NASDAQ: SHC (Sotera Health Company)

Last update: 25 Mar, 3:07PM

11.93

-0.28 (-2.29%)

Previous Close 12.21
Open 12.25
Volume 1,022,126
Avg. Volume (3M) 1,067,771
Market Cap 3,381,832,960
Price / Earnings (TTM) 74.56
Price / Earnings (Forward) 20.20
Price / Sales 2.93
Price / Book 7.93
52 Weeks Range
10.71 (-10%) — 17.08 (43%)
Earnings Date 30 Apr 2025 - 5 May 2025
Profit Margin 4.03%
Operating Margin (TTM) 34.03%
Diluted EPS (TTM) 0.160
Quarterly Revenue Growth (YOY) -6.50%
Quarterly Earnings Growth (YOY) -68.10%
Total Debt/Equity (MRQ) 580.53%
Current Ratio (MRQ) 2.75
Operating Cash Flow (TTM) 224.16 M
Levered Free Cash Flow (TTM) 107.18 M
Return on Assets (TTM) 6.76%
Return on Equity (TTM) 10.46%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bearish Bearish
Diagnostics & Research (Global) Bearish Bearish
Stock Sotera Health Company Bearish Bearish

AIStockmoo Score

0.3
Analyst Consensus 1.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators 2.0
Average 0.25

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
SHC 3 B - 74.56 7.93
TWST 3 B - - 5.25
CDNA 1 B - - 2.60
NEOG 1 B - - 0.380
CSTL 619 M - 34.63 1.26
ATLN 176 M - - 12.93

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Core
% Held by Insiders 2.44%
% Held by Institutions 93.96%

Ownership

Name Date Shares Held
Warburg Pincus Llc 31 Dec 2024 73,822,952
Sachem Head Capital Management Lp 31 Dec 2024 7,910,000
52 Weeks Range
10.71 (-10%) — 17.08 (43%)
Price Target Range
12.00 (0%) — 13.00 (8%)
High 13.00 (Piper Sandler, 8.97%) Hold
Median 12.50 (4.78%)
Low 12.00 (Barclays, 0.59%) Buy
Average 12.50 (4.78%)
Total 1 Buy, 1 Hold
Avg. Price @ Call 10.74
Firm Date Target Price Call Price @ Call
Piper Sandler 23 Apr 2025 13.00 (8.97%) Hold 10.87
Barclays 10 Apr 2025 12.00 (0.59%) Buy 10.60
28 Feb 2025 16.00 (34.12%) Buy 12.47

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria